Keefe, Bruyette & Woods Reinstates Outperform on MetLife, Announces $87 Price Target

Benzinga Newsdesk www.benzinga.com Positive 64.5%

Neg 0% Neu 0% Pos 64.5%

Keefe, Bruyette & Woods analyst Ryan Krueger reinstates MetLife (NYSE:MET) with a Outperform and announces $87 price target.